Skip to main content
SpringerLink
Log in
Book cover

Fehlgeburten Totgeburten Frühgeburten pp 141–151Cite as

Immunologie: Diagnostik und Therapie

  • Chapter
  • First Online:

  • 4388 Accesses

Zusammenfassung

Immunologische Veränderungen können bei Frauen mit Fehlgeburten identifiziert werden. Es ist jedoch unklar, ob diese Ursache oder Folge der Fehlgeburt sind. Bei der immunologischen Diagnostik werden verschiedene autoimmune und allogene Faktoren betrachtet. Zur immunmodulierenden Therapie werden u.a. Glucocorticoide, Immunglobuline, Granulocyte-Colony Stimulating Factor, Intralipide und TNF-Inhibitoren eingesetzt. Es fehlt bislang eine eindeutige Zuordnung eines diagnostischen Markers zu einer gezielten immunmodulatorischen Therapie.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Literatur

  • Akhter A, Faridi RM, Das V, Pandey A, Naik S, Agrawal S (2012) In vitro up-regulation of HLA-G using dexamethasone and hydrocortisone in first-trimester trophoblast cells of women experiencing recurrent miscarriage. Tissue Antigens 80: 126–135

    Article  CAS  PubMed  Google Scholar 

  • Ata B, Tan SL, Shehata F, Holzer H, Buckett W (2011) A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertility and Sterility 95: 1080–5.e1–2

    Google Scholar 

  • Beaman KD, Ntrivalas E, Mallers TM, Jaiswal MK, Kwak-Kim J, Gilman-Sachs A (2012) Immune etiology of recurrent pregnancy loss and its diagnosis. Am J Reprod Immunol 67: 319–325

    Article  CAS  PubMed  Google Scholar 

  • Beta J, Szekeres-Bartho J, Skyfta E, Akolekar R, Nicolaides KH (2011) Maternal serum progesterone-induced blocking factor at 11–13 weeks’ gestation in spontaneous early preterm delivery. Fetal Diagn Ther 29: 197–200

    Article  PubMed  Google Scholar 

  • Beydoun H, Saftlas AF (2005) Association of human leucocyte antigen sharing with recurrent spontaneous abortions. Tissue Antigens 65: 123–135

    Article  CAS  PubMed  Google Scholar 

  • Bingley PJ, Williams AJK, Norcross AJ, Unsworth DJ, Lock RJ, Ness AR, Jones RW, Avon Longitudinal Study of Parents and Children Study Team (2004) Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. BMJ 328: 322–323

    Article  PubMed  PubMed Central  Google Scholar 

  • Bustos D, Moret A, Tambutti M, Gogorza S, Testa R, Ascione A, Prigoshin N (2006) Autoantibodies in Argentine women with recurrent pregnancy loss. Am J Reprod Immunol 55: 201–207

    Article  CAS  PubMed  Google Scholar 

  • Carp HJA, Shoenfeld Y (2007) Recurrent spontaneous abortions in antiphospholipid syndrome: natural killer cells - an additional mechanism in a multi factorial process. Rheumatology 46: 1517–1519

    Article  CAS  PubMed  Google Scholar 

  • Choi BC, Polgar K, Xiao L, Hill JA (2000) Progesterone inhibits in-vitro embryotoxic Th1 cytokine production to trophoblast in women with recurrent pregnancy loss. Hum Reprod 15 (suppl 1): 46–59

    Article  CAS  PubMed  Google Scholar 

  • Christiansen OB, Pedersen B, Rosgaard A, Husth M (2002) A randomized, double-blind, Placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 17: 809–816

    Article  CAS  PubMed  Google Scholar 

  • Christiansen OB, Larsen EC, Egerup P, Lunoee L, Egestad L, Nielsen HS (2015) Intravenous immunoglobulin treatment for secondary recurrent miscarriage: a randomised, double-blind, Placebo-controlled trial. BJOG 122: 500–508

    Article  CAS  PubMed  Google Scholar 

  • Coomarasamy A, Williams H, Truchanowicz E, Seed PT, Small R, Quenby S, Gupta P, Dawood F, Koot YEM, Bender Atik R, et al. (2015) A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med 373: 2141–2148

    Article  CAS  PubMed  Google Scholar 

  • Coulam CB, Acacio B (2012) Does immunotherapy for treatment of reproductive failure enhance live births? Am J Reprod Immunol 67: 296–304

    Article  CAS  PubMed  Google Scholar 

  • Croy BA, van den Heuvel MJ, Borzychowski AM, Tayade C (2006) Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol Rev 214: 161–185

    Article  CAS  PubMed  Google Scholar 

  • Druckmann R, Druckmann MA (2005) Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 97: 389–396

    Article  CAS  PubMed  Google Scholar 

  • Eblen AC, Gercel-Taylor C, Shields LB, Sanfilippo JS, Nakajima ST, Taylor DD (2000) Alterations in humoral immune responses associated with recurrent pregnancy loss. Fertility and Sterility 73: 305–313

    Article  CAS  PubMed  Google Scholar 

  • Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev CD002859

    Google Scholar 

  • Ensom MHH, Stephenson MD (2011) A two-center study on the pharmacokinetics of intravenous immunoglobulin before and during pregnancy in healthy women with poor obstetrical histories. Human Reproduction 26: 2283–2288

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fawzy M, Shokeir T, El-Tatongy M, Warda O, El-Refaiey A, Mosbah A (2008) Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized Placebo-controlled study. Arch Gynecol Obstet 278: 33–38

    Article  CAS  PubMed  Google Scholar 

  • Fukui A, Kwak-Kim J, Ntrivalas E, Gilman-Sachs A, Lee SK, Beaman K (2008) Intracellular cytokine expression of peripheral blood natural killer cell subsets in women with recurrent spontaneous abortions and implantation failures. Fertility and Sterility 89: 157–165

    Article  CAS  PubMed  Google Scholar 

  • Gomaa MF, Elkholy AG, El-Said MM, Abdel-Salam NE (2014) Combined oral prednisolone and heparin versus heparin: the effect on peripheral NK cells and clinical outcome in patients with unexplained recurrent miscarriage. A double-blind Placebo randomized controlled trial. Arch Gynecol Obstet 290: 757–762

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Granato D, Blum S, Rössle C, Le Boucher J, Malnoë A, Dutot G (2000) Effects of parenteral lipid emulsions with different fatty acid composition on immune cell functions in vitro. J Parenter Enteral Nutr 24: 113–118

    Article  CAS  Google Scholar 

  • Haas DM, Ramsey PS (2013) Progestogen for preventing miscarriage. Cochrane Database Syst Rev 10: CD003511

    Google Scholar 

  • Hadziselimovic F, Geneto R, Buser M (2007) Celiac disease, pregnancy, small for gestational age: role of extravillous trophoblast. Fetal Pediatr Pathol 26: 125–134

    Article  PubMed  Google Scholar 

  • Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A (2008) Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Human Reproduction 23: 972–976

    Article  CAS  PubMed  Google Scholar 

  • Hiby SE, Walker JJ, O’shaughnessy KM, Redman CWG, Carrington M, Trowsdale J, Moffett A (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200: 957–965

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hughes GRV (2011) Hughes syndrome (the antiphospholipid syndrome): a disease of our time. Inflammopharmacology 19: 69–73

    Article  CAS  PubMed  Google Scholar 

  • Huong DL, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC (2001) A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 28: 2025–2030

    CAS  PubMed  Google Scholar 

  • Jauniaux E, Farquharson RG, Christiansen OB, Exalto N (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 21: 2216–2222

    Article  PubMed  Google Scholar 

  • de Jong PG, Kaandorp S, Di Nisio M, Goddijn M, Middeldorp S (2014) Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia. Cochrane Database Syst Rev 7: CD004734

    Google Scholar 

  • Kaandorp SP, Goddijn M, van der Post JAM, Hutten BA, Verhoeve HR, Hamulyák K, Mol BW, Folkeringa N, Nahuis M, Papatsonis DNM et al. (2010) Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 362: 1586–1596

    Article  CAS  PubMed  Google Scholar 

  • Kitaya K, Yamaguchi T, Yasuo T, Okubo T, Honjo H (2007) Post-ovulatory rise of endometrial CD16(−) natural killer cells: in situ proliferation of residual cells or selective recruitment from circulating peripheral blood? Journal of Reproductive Immunology 76: 45–53

    Google Scholar 

  • Kolho KL, Tiitinen A, Tulppala M, Unkila-Kallio L, Savilahti E (1999) Screening for coeliac disease in women with a history of recurrent miscarriage or infertility. Br J Obstet Gynaecol 106: 171–173

    Article  CAS  PubMed  Google Scholar 

  • Kumar A, Meena M, Begum N, Kumar N, Gupta RK, Aggarwal S, Prasad S, Batra S (2011) Latent celiac disease in reproductive performance of women. Fertility and Sterility 95: 922–927

    Article  PubMed  Google Scholar 

  • Kurien BT, Scofield RH (2006) Autoantibody determination in the diagnosis of systemic lupus erythematosus. Scand J Immunol 64: 227–235

    Article  CAS  PubMed  Google Scholar 

  • Kwak-Kim J, Agcaoili MSL, Aleta L, Liao A, Ota K, Dambaeva S, Beaman K, Kim JW, Gilman-Sachs A (2013) Management of women with recurrent pregnancy losses and antiphospholipid antibody syndrome. Am J Reprod Immunol 69: 596–607

    Article  CAS  PubMed  Google Scholar 

  • Lash GE, Bulmer JN (2011) Do uterine natural killer (uNK) cells contribute to female reproductive disorders? Journal of Reproductive Immunology 88: 156–164

    CAS  PubMed  Google Scholar 

  • Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J (2012) Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 67: 311–318

    Article  CAS  PubMed  Google Scholar 

  • McCracken SA, Grant KE, MacKenzie IZ, Redman CW, Mardon HJ (1999) Gestational regulation of granulocyte-colony stimulating factor receptor expression in the human placenta. Biol Reprod 60: 790–796

    Article  CAS  PubMed  Google Scholar 

  • Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL et al. (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2): 295–306

    Article  CAS  PubMed  Google Scholar 

  • Moffett A, Shreeve N (2015) First do no harm: uterine natural killer (NK) cells in assisted reproduction. Human Reproduction 30: 1519–1525

    Article  PubMed  PubMed Central  Google Scholar 

  • Moraru M, Carbone J, Alecsandru D, Castillo-Rama M, García-Segovia A, Gil J, Alonso B, Aguarón A, Ramos-Medina R, Martínez de María J et al. (2012) Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. Am J Reprod Immunol 68: 75–84

    Article  CAS  PubMed  Google Scholar 

  • Ober C, Elias S, Kostyu DD, Hauck WW (1992) Decreased fecundability in Hutterite couples sharing HLA-DR. Am J Hum Genet 50: 6–14

    CAS  PubMed  PubMed Central  Google Scholar 

  • Park-Wyllie L, Mazzotta P, Pastuszak A (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6): 385–392

    Article  CAS  PubMed  Google Scholar 

  • Pasquier E, de Saint Martin L, Bohec C, Chauleur C, Bretelle F, Marhic G, Le Gal G, Debarge V, Lecomte F, Denoual-Ziad C et al. (2015) Enoxaparin for prevention of unexplained recurrent miscarriage: a multicenter randomized double-blind Placebo-controlled trial. Blood 125: 2200–2205

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Perricone C, de Carolis C, Perricone R (2012) Pregnancy and autoimmunity: a common problem. Best Practice and Research Clinical Rheumatology 26: 47–60

    Article  CAS  PubMed  Google Scholar 

  • Porter TF, LaCoursiere Y, Scott JR (2012) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2: CD000112

    Google Scholar 

  • Quaranta M, Erez O, Mastrolia SA, Koifman A, Leron E, Eshkoli T, Mazor M, Holcberg G (2015) The physiologic and therapeutic role of heparin in implantation and placentation. Peer J 3: e691

    Article  Google Scholar 

  • Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G (2005) Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertility and Sterility 84: 980–984

    Article  CAS  PubMed  Google Scholar 

  • Rai RS, Clifford K, Cohen H, Regan L (1995) High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 10: 3301–3304

    CAS  PubMed  Google Scholar 

  • Robertson MJ, Ritz J (1990) Biology and clinical relevance of human natural killer cells. Blood 76: 2421–2438

    CAS  PubMed  Google Scholar 

  • Robson A, Harris LK, Innes BA, Lash GE, Aljunaidy MM, Aplin JD, Baker PN, Robson SC, Bulmer JN (2012) Uterine natural killer cells initiate spiral artery remodeling in human pregnancy. Faseb J 26: 4876–4885

    Article  CAS  PubMed  Google Scholar 

  • Roussev RG, Acacio B, Ng SC, Coulam CB (2008) Duration of intralipid“s suppressive effect on NK cells functional activity. Am J Reprod Immunol 60: 258–263

    Article  PubMed  Google Scholar 

  • Rychly DJ, DiPiro JT (2005) Infections associated with tumor necrosis factor-alpha antagonists. Pharmacotherapy 25: 1181–1192

    Article  CAS  PubMed  Google Scholar 

  • Sacks G (2015) Enough! Stop the arguments and get on with the science of natural killer cell testing. Hum Reprod 30(7): 1526–1531

    Article  PubMed  Google Scholar 

  • Santjohanser C, Knieper C, Franz C, Hirv K, Meri O, Schleyer M, Würfel W, Toth B (2013) Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage. Arch Immunol Ther Exp 61: 159–164

    Article  CAS  Google Scholar 

  • Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S (2004) Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10: 347–353

    Article  CAS  PubMed  Google Scholar 

  • Scarpellini F, Sbracia M (2009) Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction 24: 2703–2708

    Article  CAS  PubMed  Google Scholar 

  • Schleussner E, Kamin G, Seliger G, Rogenhofer N, Ebner S, Toth B, Schenk M, Henes M, Bohlmann MK, Fischer T et al. (2015) Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme. Ann Intern Med 162: 601–609

    Article  PubMed  Google Scholar 

  • Seshadri S, Sunkara SK (2014) Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Human Reproduction Update 20: 429–438

    Article  PubMed  Google Scholar 

  • Shoenfeld Y, Carp HJA, Molina V, Blank M, Cervera R, Balasch J, Tincani A, Faden D, Lojacono A, Doria A et al. (2006) Autoantibodies and prediction of reproductive failure. Am J Reprod Immunol 56: 337–344

    Article  CAS  PubMed  Google Scholar 

  • Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C (2010) Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized Placebo-controlled trial. Human Reproduction 25: 2203–2209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tang AW, Alfirevic Z, Quenby S (2011) Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Human Reproduction 26: 1971–1980

    Article  CAS  PubMed  Google Scholar 

  • Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S (2013) A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or Placebo when pregnant. Human Reproduction 28: 1743–1752

    Article  CAS  PubMed  Google Scholar 

  • Tatar G, Elsurer R, Simsek H, Balaban YH, Hascelik G, Ozcebe OI, Buyukasik Y, Sokmensuer C (2004) Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci 49: 1479–1484

    Article  CAS  PubMed  Google Scholar 

  • Tempfer CB, Kurz C, Bentz EK, Unfried G, Walch K, Czizek U, Huber JC (2006) A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study. Fertility and Sterility 86: 145–148

    Article  CAS  PubMed  Google Scholar 

  • Tersigni C, Castellani R, de Waure C, Fattorossi A, De Spirito M, Gasbarrini A, Scambia G, Di Simone N (2014) Celiac disease and reproductive disorders: meta-analysis of epidemiologic associations and potential pathogenic mechanisms. Human Reproduction Update 20: 582–593

    Article  CAS  PubMed  Google Scholar 

  • Thum MY, Bhaskaran S, Abdalla HI, Ford B, Sumar N, Bansal A (2008) Prednisolone suppresses NK cell cytotoxicity in vitro in women with a history of infertility and elevated NK cell cytotoxicity. Am J Reprod Immunol 59: 259–265

    Article  PubMed  Google Scholar 

  • Toth B, Jeschke U, Rogenhofer N, Scholz C, Würfel W, Thaler CJ, Makrigiannakis A (2010) Recurrent miscarriage: current concepts in diagnosis and treatment. Journal of Reproductive Immunology 85: 25–32

    Article  CAS  PubMed  Google Scholar 

  • Trowsdale J, Moffett A (2008) NK receptor interactions with MHC class I molecules in pregnancy. Semin. Immunol 20: 317–320

    Article  CAS  PubMed  Google Scholar 

  • Vaquero E, Lazzarin N, De Carolis C, Valensise H, Moretti C, Ramanini C (2000) Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 43: 204–208

    Article  CAS  PubMed  Google Scholar 

  • Wang WJ, Hao CF, Yi-Lin, Yin GJ, Bao SH, Qiu LH, Lin QD (2010) Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. Journal of Reproductive Immunology 84: 164–170

    Article  CAS  PubMed  Google Scholar 

  • Winger EE, Reed JL (2008) Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 60(1): 8–16

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gynäkologishe Endokrinologie und Fertilitätsstörungen, Im Neuenheimer Feld 440, 69120, Heidelberg, Österreich

    Ruben J. Kuon

  2. Gynäkologische Endokrinologie und Reproduktionsmedizin, Medizinische Universität Innsbruck, Anichstrasse 35, A-6020, Innsbruck, Österreich

    Bettina Toth

Authors
  1. Ruben J. Kuon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bettina Toth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Gynäkologische Endokrinologie und Reproduktionsmedizin, Medizinische Universität Innsbruck, Innsbruck, Austria

    Bettina Toth

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kuon, R.J., Toth, B. (2017). Immunologie: Diagnostik und Therapie. In: Toth, B. (eds) Fehlgeburten Totgeburten Frühgeburten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-50424-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-50424-6_18

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-50423-9

  • Online ISBN: 978-3-662-50424-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation